Volitionrx Ownership

VNRX Stock  USD 0.32  0.01  3.23%   
Volitionrx shows a total of 122.8 Million outstanding shares. Volitionrx has 15.83 % of its outstanding shares held by insiders and 21.27 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2004-09-30
Previous Quarter
102.7 M
Current Value
108.2 M
Avarage Shares Outstanding
27.4 M
Quarterly Volatility
28.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Volitionrx in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Volitionrx, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Volitionrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Volitionrx Stock Ownership Analysis

About 16.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.23. Volitionrx had not issued any dividends in recent years. VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company operates Nucleosomics a technology platform for blood test. Volitionrx operates under Diagnostics Research classification in the United States and is traded on AMEX Exchange. It employs 83 people. For more information please call the company at 646 650 1351 or visit https://volition.com.

Volitionrx Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Volitionrx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Volitionrx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Volitionrx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Reynolds Cameron John over a week ago
Acquisition by Reynolds Cameron John of 20000 shares of Volitionrx at 0.35 subject to Rule 16b-3
 
Salvatore Butera over a month ago
Disposition of 5834 shares by Salvatore Butera of Volitionrx at 0.648 subject to Rule 16b-3
 
Jacob Micallef over a month ago
Disposition of 5850 shares by Jacob Micallef of Volitionrx at 0.648 subject to Rule 16b-3
 
Forterre Gael over two months ago
Disposition of 5503 shares by Forterre Gael of Volitionrx at 0.605 subject to Rule 16b-3
 
Rootsaert Rodney Gerard over three months ago
Disposition of 4279 shares by Rootsaert Rodney Gerard of Volitionrx at 0.64 subject to Rule 16b-3
 
Reynolds Cameron John over three months ago
Acquisition by Reynolds Cameron John of 200000 shares of Volitionrx subject to Rule 16b-3
 
Batchelor Ann-louise over three months ago
Disposition of 6177 shares by Batchelor Ann-louise of Volitionrx at 0.7679 subject to Rule 16b-3
 
Nicholas Plummer over three months ago
Disposition of 5417 shares by Nicholas Plummer of Volitionrx at 0.7679 subject to Rule 16b-3
 
Salvatore Butera over three months ago
Disposition of 4462 shares by Salvatore Butera of Volitionrx at 0.7679 subject to Rule 16b-3
 
Retter Andrew over three months ago
Disposition of 4401 shares by Retter Andrew of Volitionrx at 0.7679 subject to Rule 16b-3
 
Nicholas Plummer over three months ago
Disposition of 5417 shares by Nicholas Plummer of Volitionrx at 0.7679 subject to Rule 16b-3
 
Salvatore Butera over three months ago
Disposition of 4462 shares by Salvatore Butera of Volitionrx at 0.7679 subject to Rule 16b-3

Volitionrx Outstanding Bonds

Volitionrx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Volitionrx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Volitionrx bonds can be classified according to their maturity, which is the date when Volitionrx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.